SCOLR Pharma, Inc. - Investor Relations

Investors

Overview
Annual Reports
Current SEC Filings
    2007 SEC Filings
    2006 SEC Filings
    2005 SEC Filings
    2004 SEC Filings
    2003 SEC Filings
Corporate Governance
Investor FAQ

2007 SEC Filings

12/5/2007 -
Form 8-K

11/30/2007 -
Form 8-K

Exhibit 4.1, Form of Warrant
Exhibit 5.1, Legal Opinion of DLA Piper US LLP
Exhibit 10.1, Placement Agency Agreement
Exhibit 10.2, Financial Advisory Agreement, As Amended
Exhibit 10.3, Form of Subscription Agreement
Exhibit 99.1, Press Release

11/30/2007 -
Free Writing Prospectus

11/30/2007 -
Prospectus Supplement

11/05/2007 -
Form 8-K

Exhibit 99.1, Investor Presentation

11/02/2007 -
Form 8-K

Exhibit 99.1, Press Release
Exhibit 99.2, Press Release

10/30/2007 -
Form 10-Q, For the Quarterly Period Ended September 30, 2007

Exhibit 31.1, Certification of Chief Executive Officer
Exhibit 31.2, Certification of Chief Financial Officer
Exhibit 32.1, Certification of Chief Executive Officer
Exhibit 32.2, Certification of Chief Financial Officer

10/11/2007 -
Form 8-K

Exhibit 99.1, Press Release

8/13/2007 -
Form 8-K

Exhibit 99.1, Press Release

8/7/2007 -
Form 8-K

Exhibit 99.1, Press Release

8/7/2007 -
Form 10Q, For the Quarterly period ended June 30, 2007

Exhibit 31.1, Certification of Chief Executive Officer
Exhibit 31.2, Certification of Chief Financial Officer
Exhibit 32.1, Certification of Chief Executive Officer
Exhibit 32.2, Certification of Chief Financial Officer

6/29/2007 -
Form 8-K

Exhibit 99.1, Press Release

5/8/2007 -
Form 10Q, For the Quarterly period ended March 31, 2007

Exhibit 31.1, Certification of Chief Executive Officer
Exhibit 31.2, Certification of Chief Financial Officer
Exhibit 32.1, Certification of Chief Executive Officer
Exhibit 32.2, Certification of Chief Financial Officer

4/30/2007 -
Schedule 14A Definitive Proxy Statement

4/20/2007 -
Form 8K

Exhibit 99.1, Investor Presentation

4/17/2007 -
Form 8K

Exhibit 99.1, Press Release

3/29/2007 -
Form 8k

3/16/2007 -
Form 8k

Exhibit 99.1, Press Release

3/13/2007 -
Form 10K, For the fiscal year ended December 31, 2006

Exhibit 10.6, 1995 Stock Option Plan
Exhibit 10.42, Amendment to Consulting Agreement
Exhibit 10.43, Director Compensation Program Summary
Exhibit 23.1, Consent of Grant Thornton LLP
Exhibit 31.1, Certification of Chief Executive Officer
Exhibit 31.2, Certification of Chief Financial Officer Exhibit
Exhibit 32.1, Certification of Chief Executive Officer
Exhibit 32.2, Certificationof Chief Financial Officer Exhibit